InvestorsHub Logo
Followers 373
Posts 16792
Boards Moderated 3
Alias Born 03/07/2014

Re: yogi17 post# 96080

Sunday, 06/17/2018 10:05:22 PM

Sunday, June 17, 2018 10:05:22 PM

Post# of 106830
MARCH 1st, 2018..USRM IS UNDER SEC INVESTIGATION....

MUST READ REAL NEWS....

It's in PLAIN ENGLISH...says the "commission" has ISSUED AT LEAST ONE OR MORE SUBPOENAS and is "FORMALLY INVESTIGATING" USRM for potential violations of the securities laws.

JUST RELEASED SEC 10-Q, MOST RECENT, ....SEC IS "FORMALLY" INVESTIGATING THIS POS....could END IT ALL IMO....along with the now 100% "LIVE" and progressing DOJ lawsuit...Federal Southern District Court of Florida....oh golly....TWO FEDERAL AGENCIES on um like stink on a bad monkey....why...why would that be....


https://www.sec.gov/Archives/edgar/data/1388319/000118518518000820/usstemcell10q033118.htm

PAGE 24: WORD FOR WORD, THEY ARE UNDER FORMAL SEC INVESTIGATION-

"SEC Inquiry

On or about March 1, 2018, the U.S. Securities and Exchange Commission (“Commission”), Miami Regional Office (“Commission Staff”), served a subpoena upon U.S. Stem Cell, Inc., which seeks production of certain documents and communications. The Commission Staff is conducting a formal non-public, fact-finding inquiry of U.S. Stem Cell, Inc. This investigation is neither an allegation of wrongdoing nor a finding that any violation of law has occurred. The Company is cooperating with the Commission Staff and has provided, and will continue to provide, information and documents to the Commission Staff.

At this juncture, the Company is not able to predict the duration, scope, results, or consequences of the Commission Staff’s investigation. There can be no assurance that this inquiry will be resolved in a manner that is not adverse to the Company.


Government Inquiry

By letter dated March 22, 2018 and provided to the Company on March 25, 2018, the Company received correspondence from the U.S. Department of Justice explaining that the U.S Food and Drug Administration believes that the Company (along with U.S. Stem Cell Clinic, LLC and Kristin Comella) violated the Federal Food, Drug, and Cosmetic Act. In this correspondence, the U.S. Department of Justice offered to settle the purported violation if the Company agreed to terms, including an injunctive action.

The Company has retained counsel and authorized counsel to commence discussions with the U.S. Department of Justice and believes, but cannot guarantee, that a favorable settlement will be reached. The Company is not able to predict the duration, scope, results, or consequences of the U.S. Department of Justice discussions. There can be no assurance that this matter will be resolved in a manner that is not adverse to the Company.
"

END QUOTE...

THAT SEC FORMAL INVESTIGATION is what leads to CIVIL INJUNCTIONS and often even CRIMINAL CHARGES being filed against company officers, etc. THEY'RE IN TROUBLE if you ask me...it explains EVERYTHING IMO as to why CEO Tomas COULD NOT GET THE 10-K RELEASED ON TIME....IMO, he was dealing with the SEC BREATHING DOWN HIS BACK AND NECK...the damn FEDS came a knockin AGAIN...FDA...the DOJ......

AND NOW THEE SEC...this company will be lucky to survive IMO if not be sent to BK just from the legal fees alone....let alone if they get fined CIVILLY or any company officer gets PERP WALKED or anything....STICK A FORK IN IT...their goose is past well done if you ask me....FRIED....ELECTRIFIED by high voltage...NUKED is more like it....FEDS....INCOMING....DUCK AND COVER...THIS IS NOT A DRILL...




Posts are only my amateur opinions, personal views and thoughts. They are not any type of investment advice. Do one's own due diligence.